Merck snags Chinese obesity drug in nearly $2 billion deal todayheadline
Merck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. ...
Read moreDetailsMerck will gain the exclusive global license for Chinese drugmaker Hansoh’s HS-10535, an experimental oral drug that targets GLP-1 receptors. ...
Read moreDetails
